Inflammatory Bowel Disease in African American Children Compared With Other Racial/Ethnic Groups in a Multicenter Registry  Jolanda M. White, Siobhán.

Slides:



Advertisements
Similar presentations
Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.
Advertisements

The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States  Michael D. Kappelman, Sheryl L. Rifas–Shiman,
Prevalence and Lifetime Risk of Endoscopy-related Complications Among Patients With Inflammatory Bowel Disease  Jason Ferreira, Mona Akbari, Laurie Gashin,
The Role of Psychosocial Care in Adapting to Health Care Reform
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome  Yehuda Ringel, Rachel E. Williams, Linda Kalilani,
Nitsan Maharshak, Scott E. Plevy 
Anna Krigel, Kevin O. Turner, Govind K. Makharia, Peter H. R
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Celiac Disease and Persistent Symptoms
Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient  Severin Daum, Christoph Loddenkemper,
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010  Tine Jess, Morten Frisch, Jacob Simonsen 
A 5-Year Prospective Observational Study of the Outcomes of International Treatment Guidelines for Crohn's Disease  Garret Cullen, Denise Keegan, Hugh.
Volume 138, Issue 5, Pages e2 (May 2010)
Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome–type Symptoms in Patients With Inflammatory Bowel Disease 
Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD 
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Abstracts from Around the World
Utility of Testing Patients, on Presentation, for Serologic Features of Celiac Disease  Melpakkam Srinivas, Pandurangan Basumani, Geoff Podmore, Anna Shrimpton,
Celiac Disease Patients Presenting With Anemia Have More Severe Disease Than Those Presenting With Diarrhea  Hussein Abu Daya, Benjamin Lebwohl, Suzanne.
Traveling Internationally: Avoiding and Treating Travelers' Diarrhea
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Aaron P. Thrift, PhD  Clinical Gastroenterology and Hepatology 
Millie D. Long, Hans H. Herfarth, Clare A. Pipkin, Carol Q
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
Francisco A. Sylvester, Scott Leopold, Miriam Lincoln, Jeffrey S
In Vitro Fertilization in Women With Inflammatory Bowel Disease Is as Successful as in Women From the General Infertility Population  Sveta Shah Oza,
Abnormal Liver Tests and Fatty Liver on Ultrasound
Inflammatory Bowel Disease Is Associated With Poor Outcomes of Patients With Primary Sclerosing Cholangitis  Jing Hieng Ngu, Richard Blair Gearry, Andrew.
New Models of Gastroenterology Practice
Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta 
David H. Bruining, William J. Sandborn 
Prevalence and Lifetime Risk of Endoscopy-related Complications Among Patients With Inflammatory Bowel Disease  Jason Ferreira, Mona Akbari, Laurie Gashin,
Amnon Sonnenberg  Clinical Gastroenterology and Hepatology 
Kavita Patel, Elise Presser, Meaghan George, Mark McClellan 
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis  Siddharth.
Issue Highlights Clinical Gastroenterology and Hepatology
Volume 140, Issue 6, Pages e2 (May 2011)
Issue Highlights Clinical Gastroenterology and Hepatology
Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population- based Cohort Study With 30 Years of Follow-up Evaluation  Michael.
Initiating Azathioprine for Crohn's Disease
Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies  Hai Yun.
Antje Timmer, Alexandra Bauer, Axel Dignass, Gerhard Rogler 
Medical Malpractice in Gastroenterology
Volume 114, Issue 5, Pages (May 1998)
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Thrombocytopenia With Abnormal Liver Function Tests
Meenakshi Bewtra, Chinyu Su, James D. Lewis 
Incidence of Neoplasms in Patients Who Develop Sustained Leukopenia During or After Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease  William.
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
Rocco Ricciardi, Robert D. Madoff, David A. Rothenberger, Nancy N
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Christopher Hung, Desmond Leddin 
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism?  John S. Leeds, David S. Sanders 
Issue Highlights Clinical Gastroenterology and Hepatology
Coloduodenal Fistula in Crohn’s Disease
Black and White Liver Clinical Gastroenterology and Hepatology
Rintaro Hashimoto, Akimichi Chonan 
The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States  Michael D. Kappelman, Sheryl L. Rifas–Shiman,
Medical Therapy for Refractory Pediatric Crohn’s Disease
Issue Highlights Clinical Gastroenterology and Hepatology
Rintaro Hashimoto, Akimichi Chonan 
The Role of Psychosocial Care in Adapting to Health Care Reform
Thiopurines and Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Meta-analysis  Tine Jess, Anthony Lopez, Mikael Andersson,
Presentation transcript:

Inflammatory Bowel Disease in African American Children Compared With Other Racial/Ethnic Groups in a Multicenter Registry  Jolanda M. White, Siobhán O'Connor, Harland S. Winter, Melvin B. Heyman, Barbara S. Kirschner, George D. Ferry, Stanley A. Cohen, Robert N. Baldassano, Terry Smith, Traci Clemons, Benjamin D. Gold  Clinical Gastroenterology and Hepatology  Volume 6, Issue 12, Pages 1361-1369 (December 2008) DOI: 10.1016/j.cgh.2008.07.032 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Disease classification of the pediatric IBD patient cohort we analyzed comparing those AA patients with non-AA patients. Statistically significant differences were observed between AA children with Crohn's disease compared with non-AA (78% vs 59%); that is, proportionally more AA children had Crohn's disease. Differences also were significant when comparing AA with non-AA children with UC (18% vs 30%) and IC (4% vs 10%); whereas more non-AA children proportionally had UC or IC than did their AA counterparts. *P < .001; **P = .003; ***P = .024. Clinical Gastroenterology and Hepatology 2008 6, 1361-1369DOI: (10.1016/j.cgh.2008.07.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 Gender classification of our pediatric IBD cohort comparing males with females whether AA or non-AA. There were no statistically significant differences in the gender distribution in either main racial/ethnic categories. *P < .001; **P + .003; ***P = .024. Clinical Gastroenterology and Hepatology 2008 6, 1361-1369DOI: (10.1016/j.cgh.2008.07.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 The proportion of AA children versus non-AA children diagnosed after the age of 12 years by disease category (all IBD, CD, UC, or IC). Interestingly, for reasons yet to be explained, statistically more AA children were diagnosed with all IBD, UC, or IC compared with non-AA children. *P < .001; **P = .009; ***P = .010. Clinical Gastroenterology and Hepatology 2008 6, 1361-1369DOI: (10.1016/j.cgh.2008.07.032) Copyright © 2008 AGA Institute Terms and Conditions

Figure 4 The proportion of AA children versus non-AA children with symptom onset after the age of 12 years by disease category (all IBD, CD, UC, or IC). In our cohort, statistically more AA children had symptom onset whether they had all IBD, CD, or UC compared with non-AA children. *P < .001; **P = .008; ***P = .005. Clinical Gastroenterology and Hepatology 2008 6, 1361-1369DOI: (10.1016/j.cgh.2008.07.032) Copyright © 2008 AGA Institute Terms and Conditions